These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27816383)

  • 1. Role of Interleukin-22 in chronic liver injury.
    Carmo RF; Cavalcanti MSM; Moura P
    Cytokine; 2017 Oct; 98():107-114. PubMed ID: 27816383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis.
    Fabre T; Molina MF; Soucy G; Goulet JP; Willems B; Villeneuve JP; Bilodeau M; Shoukry NH
    Sci Immunol; 2018 Oct; 3(28):. PubMed ID: 30366940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation.
    Taru V; Szabo G; Mehal W; Reiberger T
    J Hepatol; 2024 Nov; 81(5):895-910. PubMed ID: 38908436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interleukin-20 Cytokine Family in Liver Disease.
    Caparrós E; Francés R
    Front Immunol; 2018; 9():1155. PubMed ID: 29892294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.
    Wu LY; Liu S; Liu Y; Guo C; Li H; Li W; Jin X; Zhang K; Zhao P; Wei L; Zhao J
    Clin Immunol; 2015 May; 158(1):77-87. PubMed ID: 25771172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of liver injury to evaluate paracrine and endocrine effects of bone marrow mesenchymal stem cells.
    Huang CK; Lee SO; Luo J; Wang R; Dang Q; Chang C
    Methods Mol Biol; 2014; 1213():69-79. PubMed ID: 25173375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 cytokines in liver fibrosis and liver cancer.
    Molina MF; Abdelnabi MN; Fabre T; Shoukry NH
    Cytokine; 2019 Dec; 124():154497. PubMed ID: 30097286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis - mouse models and relevance in human liver diseases.
    Mederacke I
    Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases.
    Al-Shaebi F; Wenzhang L; Hezam K; Almezgagi M; Wei L
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107023. PubMed ID: 33129098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of the atypical cadherin FAT1 in chronic liver disease.
    Valletta D; Czech B; Thasler WE; Müller M; Bosserhoff AK; Hellerbrand C
    Biochem Biophys Res Commun; 2012 Sep; 426(3):404-8. PubMed ID: 22959770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
    Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
    Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
    Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
    J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
    Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
    Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?
    Yi HS; Jeong WI
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():99-104. PubMed ID: 23855303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
    Naseem S; Hussain T; Manzoor S
    Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.